"","Blank 1","Frequency","Blank 2","Frequency"
"88","ability to understand and the willingness to sign a written",99,"document                                                                                                                                      ",106
"38","all patients and / or their parents or legal guardians must sign a written",22,"                                                                                                                                             ",51
"61","all patients and / or their parents or legally authorized representatives must sign a written",15,"assent when appropriate will be obtained according to institutional guidelines                                                                                                                         ",17
"87","the patient or a legally authorized representative must provide study specific",10,"prior to study entry                                                                                                                                        ",16
"1","patients must have signed an approved",9,"and authorization permitting release of personal health information                                                                                                                                   ",8
"226","patient must provide study specific",9,"document according to institutional guidelines                                                                                                                   ",5
"204","patients must be able to provide written",6,"prior to step 1 registration                                                                                                                                       ",3
"224","patients must provide study specific",4,"form                                                                                                                                          ",2
"12","diagnostic or laboratory studies performed exclusively to determine eligibility for this trial must only be done after obtaining written",3,"for themselves                                                                                                                       ",2
"26","written",3,"document inclusive of assent where appropriate according to institutional guidelines                                                                                                                    ",2
"141","ability to understand and willingness to sign a written",3,"prior to study entry and for patients treated in the united states u . s . authorization permitting release of personal health information                                                                                                                    ",2
"220","ability of subject or legally authorized representative lar to understand and the willingness to sign a written",3,"prior to registration                                                                                                                                           ",2
"239","patient must be able to provide study specific",3,"and health insurance portability and accountability act hipaa authorization                                                                                                                                  ",1
"4","signed",2,"indicating their understanding of the investigational nature and the risks of this study when appropriate pediatric patients will be included in all discussions in order to obtain verbal assent                                                                                           ",1
"17","ability to provide",2,"according to institutional guidelines must be obtained                                                                                                                                         ",1
"20","the patient or parent / guardian is able to understand the consent and is willing to sign a written",2,"/ assent                                                                                                                                          ",1
"85","the patient must provide study specific",2,"or is likely to interfere with the ability to comply with the protocol stipulations                                                                                                                         ",1
"203","inability to provide",2,"by subject age > = 18 years or by parent / guardian subject age < 18 years information will be provided to potential subjects and their parents / guardians as appropriate by oral discussion with opportunity for question and answer and the written informed consent document subjects less than 18 years of age capable of giving assent will be included in these discussions and will be asked for written assent on the same document as the parents / guardians give consent if feasible both parents or guardians will be included in these discussions and will be asked to sign the written consent document if a second parent or guardian is unavailable this will be explained in writing on the written consent document if subjects age 18 years or older are unable to provide informed consent then they will not be enrolled in this study",1
"230","signed study specific",2,"from all patients or their legal guardians if the patient is < 18 years old when appropriate pediatric patients will be included in all discussions this can be accomplished through one of the following mechanisms a the nci pob screening protocol b an institutional review board irb approved institutional screening protocol or c the study specific protocol documentation of the informed consent for screening will be maintained in the patientï s research chart studies or procedures that were performed for clinical indications not exclusively to determine eligibility may be used for baseline values even if the studies were done before informed consent was obtained                      ",1
"2","ability to give",1,"or if the oncology physician determines the patient to not have decision making capacity a patient designated health care proxy or authorized representative per institutional policies must sign consent by the baseline visit if the participant is found to be impaired on the blessed orientation memory concentration test bomc during screening they must have a health care proxy or authorized representative to be eligible to enroll                                                                            ",1
"3","all patients or their legal guardians if the patient is < 18 years old or durable power of attorney dpa must sign a document of",1,"or assessment of response or anticipated toxicities this includes uncontrolled intercurrent illness including but not limited to ongoing or active infection                                                                                                         ",1
"5","able and willing to sign",1,"all subjects must sign an informed consent form indicating their understanding of the investigational nature and risks of the study before any protocol related studies are performed                                                                                                                   ",1
"6","procurement patient able to give",1,"form icf and authorization to use protected health information in accordance with national and local subject privacy regulations                                                                                                 ",1
"7","treatment patient able to give",1,"from all patients which can be accomplished using the nci pob screening protocol studies or procedures that were performed for clinical indications not exclusively to determine eligibility may be used for screening or baseline values even if the studies were done before informed consent was obtained if the patient agrees                                                                            ",1
"8","a medical or psychiatric illness that precludes ability to give",1,"or compliance with study procedures                                                                                                                      ",1
"10","willingness to sign the healthy volunteer",1,"ic for trial participation must be signed and dated by the patient and the investigator prior to enrollment                                                                                                                              ",1
"11","medical or psychiatric illness that would in the opinion of the investigator preclude participation in the study or the ability of patients to provide",1,"from all patients which can be accomplished using the study specific informed consent or another consent such as the national cancer institute nci pediatric oncology branch pob screening protocol studies or procedures that were performed for clinical indications not exclusively to determine eligibility may be used for screening or baseline values even if the studies were done before informed consent was obtained if the patient agrees                                                            ",1
"13","cognitive impairment history of medical or psychiatric disease other uncontrolled intercurrent illness active substance abuse or social circumstances which in the view of the principal investigator pi would preclude safe treatment or the ability to give",1,"indicating that they are aware of the investigational nature of the study and are aware that participation is voluntary patients must be made aware of their other treatment options                                                                                                                ",1
"14","able to provide",1,"form prior to receiving any study related procedure                                                                                                                 ",1
"15","all patients and / or their parent or legal guardian must sign a written",1,"and comply with the requirements of the study                                                                                                                                ",1
"16","patients must not suffer from medical or psychiatric conditions that would interfere with protocol compliance the ability to provide",1,"patient assent is also recommended when applicable according to each institutionï s policy                                                                                                                      ",1
"18","patient or appointed surrogate decision maker or legally authorized representative must have ability to understand the purpose and risks of the study and willingness to provide a signed and dated",1,".                                                                                                                                  ",1
"19","inability to understand and inability to provide",1,"and authorization permitting release of personal health information individuals with impaired decision making capacity are not eligible to participate on the study                                                                                                                     ",1
"21","inclusion criteria for stratum c the patient or parent / guardian is able to understand the consent and is willing to sign a written",1,"and authorization permitting release of personal health information prior to study entry                                                                                                                          ",1
"23","signed written",1,"document subjects must be willing to adhere to dose and visit schedules                                                                                                                           ",1
"24","other uncontrolled concurrent illness that would preclude study participation or psychiatric illness or social challenges that would entail unreasonable risk or preclude",1,"to participate                                                                                                                                      ",1
"25","inability to understand and sign",1,"document and to undergo tumor biopsies in the expansion phase                                                                                                                             ",1
"27","any perceived inability to directly and without the means of a legal guardian provide",1,"document subjects with impaired decision making capacity are not eligible                                                                                                                          ",1
"28","medical or psychiatric illness or social situations that would in the opinion of the investigator preclude participation in the study or the ability of patients to provide",1,"document consent will be obtained by day 14 of acdvp 16 induction regimen                                                                                                                          ",1
"29","recurrent / progressive dipg stratum 1 the patient or parent / guardian is able to understand the consent and is willing to sign a written",1,"document or a parent / guardian able to do the same                                                                                                                            ",1
"30","non progressed dipg stratum 2 the patient or parent / guardian is able to understand the consent and is willing to sign a written",1,"document if a patient has impaired decision making capacity a legally authorized representative patients will be allowed to participate                                                                                                                    ",1
"31","patients must be able to understand and sign an",1,"prior to study entry including consent for mandatory tissue submission for egfr and for oropharyngeal patients hpv analyses                                                                                                                          ",1
"32","signed dated",1,"prior to study entry including consent for mandatory tissue submission for central review                                                                                                                               ",1
"35","patients must have signed",1,"prior to study entry including consent for mandatory tissue submission for epidermal growth factor receptor egfr analysis and for oropharyngeal cancer patients human papilloma virus hpv analysis                                                                                                                 ",1
"36","participant or legal representative must understand the investigational nature of this study and sign an independent ethics committee / institutional review board approved written",1,"prior to study entry including consent for mandatory screening of tissue                                                                                                                                 ",1
"37","mental impairment that may compromise the ability to give",1,"prior to study entry including the mandatory pre treatment plasma ebv dna assay                                                                                                                               ",1
"53","each patientï s parents or legal guardians must sign a written",1,"prior to study entry including consent for mandatory tumor tissue serum and blood submission for immune correlatives all patients and p16 analysis oropharyngeal cases only                                                                                                             ",1
"83","patients must have the ability to understand and sign an approved",1,"prior to any study specific procedures                                                                                                                                         ",1
"86","the patient or legally authorized representative must provide study specific",1,"prior to study registration                                                                                                                                  ",1
"95","ability to understand and the willingness to provide written",1,"prior to study specific screening procedures with the understanding that the patient has the right to withdraw from the study at any time                                                                                                                     ",1
"115","tumor biopsy sequencing ability to understand and the willingness to sign a written",1,"prior to study entry .                                                                                                                                 ",1
"122","ability of patient to understand and the willingness to sign a written",1,"",NA
"127","patient and / or guardian have the ability to understand and the willingness to sign a written",1,"",NA
"135","participants must be able to understand and willing to sign a written",1,"",NA
"147","ability to understand and to sign a written",1,"",NA
"169","able to understand and willingness to sign a written",1,"",NA
"179","ability of subject or legally guardians if the patient is < 18 years old to understand and the willingness to sign a written",1,"",NA
"185","ability to understand and the willingness to sign an institutional review board irb approved written",1,"",NA
"200","participant willing to provide a written",1,"",NA
"201","able to give",1,"",NA
"202","ability to provide written",1,"",NA
"205","unable to provide",1,"",NA
"206","patient must have given written",1,"",NA
"207","ability to understand and willing to provide",1,"",NA
"208","participant is unable to provide",1,"",NA
"213","capable and willing to provide",1,"",NA
"214","be able to provide written",1,"",NA
"218","patients must be willing and able to provide a written",1,"",NA
"223","ability of a patient or a legally authorized representative lar to understand and the willingness to sign a written",1,"",NA
"232","provision of",1,"",NA
"243","the ability to provide written",1,"",NA
"249","patient must have provided study specific",1,"",NA
"251","patients must sign a study specific",1,"",NA
